Insider trade

Supernus Pharmaceuticals, Inc. (SUPN): Director sold ~$388K

Charles W Iii Newhall, Director at Supernus Pharmaceuticals, Inc., sold ~$388K of Supernus Pharmaceuticals, Inc. shares.

~$388K
Approx. value · 11K sh @ $36.24: 130K
Holds after · shares reported

Traded: Nov 11, 2024
Filed: Nov 12, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Nov 7, 2024Insider · 3 peopleInsiders: 3 sales (~$5.7M)
Nov 8, 2024Insider · 3 peopleInsiders: 3 sales (~$5.2M)
Nov 11, 2024 · this disclosureInsiderDirector sold ~$388K of SUPN shares in the open market

What came next

Dec 3, 2024Insider · 1 personInsiders: 2 sales (~$788K)
Jan 27, 2025InsiderOfficer sold ~$102K of SUPN shares in the open market
Jan 28, 2025InsiderOfficer sold ~$28K of SUPN shares in the open market
Feb 4, 2025InsiderOfficer sold ~$376K of SUPN shares in the open market
Feb 21, 2025InsiderOfficer sold ~$36K of SUPN shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Supernus Pharmaceuticals, Inc.

OQRO holds no insider, Congress, fund or contract record for Supernus Pharmaceuticals, Inc. dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SUPN page.

Other recent filings by Charles W Iii Newhall, Director

The full history of Charles W Iii Newhall, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Supernus Pharmaceuticals, Inc.

Everything OQRO holds on this company is on its SUPN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data